It is pretty clear that one list is just a bit longer than another.

Now ConAgra's product focus - as shown below - is not particularly trendy or exposed to structural health shifts. It is though pretty mainstream America which is why the above sales mix is interesting.
To be fair, price-mix is far more important and within their core Consumer Foods division they achieved a flat result on this metric. Put it all together though and their fiscal 2014 will be a single digit growth year. They are aiming for 10%+ on a medium-term basis.
ConAgra's shares have been volatile over the last year as shown below as the company has struggled to hit targets following some material M&A (Ralcorp). The other issue they have is debt: at US$9bn it is over x4 ebitda. Whilst the company is anticipating a free cash flow yield of around 8% over the next year which will allow not only the payment of a 3.5%+ dividend but just over US$500m worth of debt reduction, clearly the finances remain tough. The headline rating at around x14 prospective EV/ebita also smacks of a need to believe in the turnaround if you are going to invest.
ConAgra shares per se do not strike me as that interesting today. The insights their corporate communication provided though is quite fascinating...and not particularly indicative of underlying economic strength.


No comments:
Post a Comment